Buy Lipo-C LC526 Online

Product Details: Lipo-C LC526

What is Lipo-C LC526?

Lipo-C LC526 is a seven-compound research formulation. It combines seven distinct nutrient compounds in a single 10ml solution. Each vial delivers L-Carnitine 300mg, Methionine 25mg, Inositol 50mg, Choline 50mg, Vitamin B12 1mg, Vitamin B6 50mg, and NADH 50mg. Total delivery is 526mg per 10ml vial.

L-Carnitine is a mitochondrial fatty-acid transport compound, present at a higher concentration in this formulation than in comparable blends. Methionine, Inositol, and Choline are classic lipotropic research compounds studied for liver fat metabolism. Vitamins B12 and B6 are water-soluble coenzyme-precursor vitamins, and NADH is the reduced form of nicotinamide adenine dinucleotide, a coenzyme central to cellular energy production. In preclinical models, these compounds are studied to assess their influence on cellular signaling pathways involved in:

• Mitochondrial fatty-acid transport and energy metabolism
• Hepatic lipid transport
• Coenzyme-dependent methylation, and
• NAD-pathway cellular energy production

This liquid solution format is used in research settings as a delivery method that allows investigators to study combined nutrient uptake and metabolism without preparing and mixing seven separate compounds.

Disclaimer: Lipo-C LC526 is a research compound not approved by the U.S. Food and Drug Administration (FDA) for human or veterinary use as this co-blended formulation. It is not intended to diagnose, treat, cure, or prevent any disease. This product is strictly for laboratory research purposes only.

ATTENTION: This product is strictly for LABORATORY AND RESEARCH PURPOSES ONLY. Not for human or veterinary use.

Mechanism of Action of Lipo-C LC526

L-Carnitine Working in Preclinical Models

L-Carnitine is thought to work primarily through transport of long-chain fatty acids across the mitochondrial membrane, a rate-limiting step in fatty-acid oxidation research. At the elevated 300mg concentration used in this formulation, it is a primary focus of this blend's energy-metabolism research profile.

Key mechanistic observations from laboratory studies:

• Fatty-acid transport: L-Carnitine is thought to shuttle fatty acids into the mitochondrial matrix for beta-oxidation.
• Energy metabolism research: Studies in preclinical settings have observed carnitine's role in skeletal-muscle fuel-metabolism research.

Methionine, Inositol, and Choline Working in Preclinical Models

Methionine, Inositol, and Choline are thought to work together as classic lipotropic agents, supporting hepatic lipid transport and phospholipid synthesis. This is thought to affect liver fat accumulation research in experimental models.

Key mechanistic observations from laboratory studies:

• Methyl-donor activity: Methionine is thought to support methylation reactions relevant to lipid metabolism research.
• Phospholipid synthesis: Choline is thought to support phosphatidylcholine synthesis, relevant to hepatic lipid-transport research.
• Cell-signaling modulation: Inositol has been observed influencing cell-signaling markers in preclinical research models.

Vitamin B12, Vitamin B6, and NADH Working in Preclinical Models

Vitamin B12 and B6 are thought to act as coenzyme or coenzyme-precursor components involved in methylation and amino-acid metabolism pathways. NADH is thought to act as a direct coenzyme in cellular energy production, participating in the electron-transport chain.

NADH is the reduced (electron-carrying) form of NAD⁺ — it donates a hydride ion (H⁻) to Complex I's FMN prosthetic group to initiate ETC electron flux. In permeabilized cell preparations, exogenous NADH bypasses the need for intracellular metabolic reduction and directly sustains Complex I-dependent O₂ consumption and ΔΨm. 

Key mechanistic observations from laboratory studies:

• Methylation-cycle support: Vitamin B12 (cyanocobalamin) is thought to support methionine synthase coenzyme activity relevant to methylation research.
• Amino-acid metabolism: Vitamin B6 (pyridoxine) is thought to support amino-acid and neurotransmitter metabolism research.
• Cellular energy production: NADH is thought to donate electrons in the mitochondrial electron-transport chain, relevant to ATP-production research.

Chemical Properties of Lipo-C LC526

L-Carnitine

Methionine

Inositol

Choline

Vitamin B12

Vitamin B6

NADH

Blend Specification

Research Applications of Lipo-C LC526

1. High-Concentration Fatty-Acid Transport Research L-Carnitine's elevated 300mg concentration in this formulation makes it a tool for investigating mitochondrial fatty-acid transport and energy-metabolism research at higher dose ranges than standard lipotropic blends.
2. Hepatic Lipid Metabolism Research Methionine, Inositol, and Choline's classic lipotropic pairing supports research into liver fat transport and phospholipid synthesis in metabolic research models.
3. NAD-Pathway Cellular Energy Research NADH's direct role in the mitochondrial electron-transport chain makes it a tool for investigating cellular energy production and ATP-synthesis research.
4. Combination Nutrient-Pathway Research Because these seven compounds span fatty-acid transport, hepatic lipid metabolism, and NAD-pathway energy production, researchers use this blend to study combined nutrient-metabolism effects across multiple systems.

Risk and Handling Precautions

Risk Tier: LOW

This rating reflects all seven compounds' long-established safety history as nutritional and biochemical research substances, several of which are recognized by NIH's Office of Dietary Supplements, while noting that this specific seven-compound co-blended research solution  particularly at its elevated carnitine concentration  has not itself been evaluated by the FDA. Researchers must observe the following precautions at all times.

Handling Precautions: Lipo-C LC526 should be handled by trained laboratory personnel only. Use appropriate personal protective equipment (PPE) at all times, including gloves and eye protection. Avoid direct skin contact, inhalation, or accidental exposure during laboratory handling.

Exposure Risks: All seven compounds have a long safety history as nutritional research substances, though no formal human exposure data exists specific to this exact seven-compound co-blended solution or its elevated carnitine concentration.

Storage: Refrigerate at 2–8°C; protect from light AND oxygen. Do not freeze. Where available, store NADH-containing solutions under inert gas headspace (argon or nitrogen); minimise pipetting time in open air. Check the batch Certificate of Analysis for lot-specific guidance. Do not use it if the seal has been compromised.

Toxicity and Data Limitations: No chronic toxicity data exist for this specific blend ratio. Individual-compound safety data comes from nutrition and biochemical research recognized by NIH, but findings cannot be assumed to apply directly to this co-blended vendor formulation.

Why Choose BehemothLabz for Research-Grade Lipo-C LC526?

BehemothLabz supplies Lipo-C LC526 for laboratory and research purposes. Every batch is independently tested by third-party laboratories for purity and identity. A Certificate of Analysis is publicly available for each lot. BehemothLabz does not self-certify.

The compound is USA-made and held to research-grade standards. It is available strictly to qualified researchers for use in controlled laboratory environments.

BehemothLabz Disclaimer

ATTENTION: All BehemothLabz products are strictly for LABORATORY AND RESEARCH PURPOSES ONLY. They are not to be used for any human or veterinary purposes.

Please make sure you go through the Terms and Conditions and familiarize yourself with them, as it is important. Kindly research the scientific uses of this product before making any purchases. Make note that the packaging and labels of the product may differ from those shown on the website.

Buying the product means you agree to our Terms and Conditions. You can contact our customer service team at support@behemothlabz.com if you are not fully satisfied with the product.

Lipo-C LC526 Research FAQs

Is any compound in this blend banned by WADA? 

No. None of the seven compounds  L-Carnitine, Methionine, Inositol, Choline, Vitamin B12, Vitamin B6, or NADH  appear on the World Anti-Doping Agency's Prohibited List. This is directly checkable at wada-ama.org/en/prohibited-list; none of these fall under any S-category covered by that list.

Is any compound in this blend FDA-approved? 

Two of the seven, in specific, separate forms unrelated to this blend. Levocarnitine is FDA-approved as the prescription drug Carnitor, and cyanocobalamin injection is separately FDA-approved as a prescription B12 injectable  both verifiable via the FDA's DailyMed database at dailymed.nlm.nih.gov. Neither approval applies to this seven-compound research-grade blend, which is not FDA-approved as sold.

Does the NIH recognize these as real nutrients? 

Yes, for most of them. Methionine, Choline, and Vitamin B6 each have recognized nutritional roles documented by the NIH's Office of Dietary Supplements (ods.od.nih.gov), and Vitamin B12 is documented in that same database's B12 fact sheet. Inositol and NADH are documented in NIH-affiliated biochemical literature, though not under a dedicated standalone ODS fact sheet the way an essential vitamin would be.

Can I verify the chemical identity of each compound independently? 

Yes. Each compound has a public PubChem entry maintained by NCBI (part of NIH): L-Carnitine (CID 288), Methionine (CID 6137), Inositol (CID 892), Choline (CID 6209), Vitamin B12 (CID 166596686), Vitamin B6 (CID 1050), and NADH (CID 439153). These can be checked directly at pubchem.ncbi.nlm.nih.gov.

What does each vial deliver? 

Each 10ml vial delivers L-Carnitine 300mg, Methionine 25mg, Inositol 50mg, Choline 50mg, Vitamin B12 1mg, Vitamin B6 50mg, and NADH 50mg, totaling 526mg.

Is this blend approved for human use? 

No. This seven-compound co-blended formulation has not been evaluated or approved by the FDA. Injectable amino acid and vitamin blends require compounding pharmacy prescriptions for pharmaceutical use in the USA. This research-grade formulation is for laboratory use only. 

What purity standard does BehemothLabz provide for this blend? 

Every batch is independently tested by third-party laboratories. All seven compounds are verified at ≥99% purity by HPLC analysis. A Certificate of Analysis confirming purity and molecular identity is available per lot.

How should Lipo-C LC526 be stored? 

Store at 2–8°C in a dry, dark environment protected from light and moisture. Check the batch Certificate of Analysis for lot-specific guidance. Do not use it if the seal has been compromised.

References

1. National Center for Biotechnology Information (NCBI). PubChem entries for L-Carnitine (CID 288), Methionine (CID 6137), Inositol (CID 892), Choline (CID 6209), Vitamin B12 (CID 166596686), Vitamin B6 (CID 1050), and NADH (CID 439153). National Institutes of Health. Available at: https://pubchem.ncbi.nlm.nih.gov
2. National Institutes of Health, Office of Dietary Supplements. Choline – Health Professional Fact Sheet; Vitamin B6 – Health Professional Fact Sheet; Vitamin B12 – Health Professional Fact Sheet. Available at: https://ods.od.nih.gov/factsheets/list-all/
3. U.S. Food and Drug Administration / DailyMed. Carnitor (levocarnitine) and Cyanocobalamin Injection, USP  Drug Labels. Available at: https://dailymed.nlm.nih.gov
4. World Anti-Doping Agency. The 2026 Prohibited List International Standard (confirms none of the seven compounds in this blend are listed). Available at: https://www.wada-ama.org/en/prohibited-list
5. Hatefi Y. The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem. 1985;54:1015–69. PMID 2862839. 

Please click here to access instructions on how to make a payment.